Oil and Aroma

Several Experiences in this house name aromatic oil as something you can have if you would like it. Almost nowhere in the wider industry is that option actually explained — what the oil is, why there is oil at all, what is dissolved in it, and what can go wrong. This page is that explanation. It is written for an adult who wants to understand what will be on her skin for ninety minutes, and it assumes she would rather be told the boring truth than the flattering one.

One disclosure belongs at the top rather than at the bottom. This house sells bodywork with an aromatic oil option, and it therefore has a commercial interest in aroma sounding effective. That is a conflict of interest, and naming it does not dissolve it. The only thing that can partly answer it is to report the research honestly even where the research is unflattering — which is what the evidence section below does, including the systematic reviews that found no convincing benefit at all. If this page had wanted to sell you something, it would have been much shorter and much more confident.

Two boundaries hold for everything that follows. Nothing here is medical advice, and no oil is recommended anywhere on this page for any condition, symptom or purpose — not one. Nothing here assumes anything about your health. Where the text describes a caution, the instruction attached to it is always the same: take the question to a qualified professional, which means a physician, a pharmacist, or a properly trained clinical aromatherapist, and not a shop, an influencer or a website, including this one.

The first answer is friction, and it is more interesting than it sounds. A dry hand on dry skin does not slide; it drags. Dragging pulls at hair follicles and at the surface of the skin, it reddens, it stings slightly, and — most importantly for the work — it makes the body brace. A person who is being dragged on cannot let go, because the sensation keeps announcing itself at the surface. Lubricant is what allows a hand to deliver pressure downward into tissue without also delivering shear sideways across the skin. That separation of pressure from shear is the entire mechanical point of oil.

The second answer is continuity. A long stroke — sacrum to shoulder, or heel to hip — is one of the few things in bodywork that reliably reorganises a person’s sense of where their body ends. It only works if it is continuous. Without lubricant, a long stroke breaks into a series of small snags, and the nervous system reads a series rather than a whole. The same logic governs a detail practitioners rarely explain: good practice keeps one hand on the body when re-oiling, because releasing contact entirely restarts the session in miniature. Oil is applied to the hands and warmed there first, not poured cold onto a back.

The third answer is that the amount of oil is itself a technique, and getting it wrong ruins the work in both directions. Too little and the hand snags. Too much and the hand hydroplanes: pressure that was meant to engage fascia and the deeper layers simply slides across the surface, and the recipient feels a lot of movement and very little contact. Thinner, faster-absorbing oils suit work that wants grip; richer, slower ones suit long gliding work. A practitioner who says "I use a slightly drier oil for the back and a slower one for the legs" is not being precious — they are choosing how much the hand is allowed to slip.

Finally, the unglamorous logistics are part of the craft. Oil transfers to linen, to hair, to clothing. A room that offers oil work needs towels it does not mind, a way of protecting hair that is agreed rather than assumed, warmth in the room (oil on skin cools by evaporation and a cold room turns a relaxing stroke into a shiver), and something to offer afterwards — a shower, or simply the information that a light residue is normal and will not come out of silk. None of that is atmosphere. It is the difference between a person relaxing and a person quietly worrying about her blouse.

The oil that does the actual work of gliding is the carrier. Most carriers are plant fats: triglycerides, meaning three fatty acids attached to a glycerol backbone. Their behaviour on skin — how fast they sink in, how long they slip, how heavy they feel, how quickly they spoil — is largely a consequence of which fatty acids dominate and how saturated they are. Jojoba is the interesting exception, and it is worth starting there.

Jojoba is not a fat at all. It is a liquid wax: roughly 97–98 per cent long-chain esters of fatty acids and fatty alcohols, chiefly C20 and C22 monounsaturated chains, with essentially no glycerol. That single structural fact explains nearly everything practitioners like about it. Wax esters of that kind are highly resistant to oxidation, so jojoba keeps far longer than a seed oil and does not develop the stale-crayon smell of a rancid bottle. It feels light rather than greasy, leaves a thin non-tacky film, and is chemically unexciting, which in a product going onto skin for an hour is a virtue. It is also the most expensive of the common carriers, which is why it appears more often in a blend than as the whole bottle.

Sweet almond oil is the classic Western massage carrier and behaves like one: medium weight, a long comfortable slip, an oleic-to-linoleic ratio in the region of two or three to one, which is close to the proportion found in skin’s own surface lipids. Its drawback is chemical. It is highly unsaturated and it is light-sensitive; it oxidises and turns rancid comparatively quickly, and once it has, it belongs in the bin rather than on a body. Grapevine seed oil sits at the other end: extremely polyunsaturated, with polyunsaturates approaching ninety per cent of its fat and linoleic acid dominant. That makes it light, fast-absorbing and inexpensive — and the quickest of this group to spoil. Fractionated coconut oil is the opposite proposition again: it is caprylic/capric triglyceride, a medium-chain fraction with the long-chain components removed, fully saturated, therefore very stable, very long-lived, thin, colourless, largely non-staining, and inclined to sit on the surface rather than sink in, which makes it a long-glide oil rather than a grip oil.

So the choice is a set of trade-offs, not a ranking. How long is the session, and does the oil need to survive ninety minutes without a top-up? Does this work want grip or glide? Will it go onto a face, where residue matters more? How often is the bottle opened, and how long has it been open? What does the linen budget look like? A practitioner who can answer "why this oil" in those terms is doing something different from one who says an oil is nourishing.

Three cautions belong with carriers specifically, and they are practical rather than alarming. First, allergy: cold-pressed and unrefined nut-derived carriers such as sweet almond can retain residual seed proteins, and anyone with a nut allergy should say so before a session rather than after it. Whether topical nut oils can contribute to the development of an allergy is genuinely unsettled in the literature, which is a reason for caution and not a reason for confidence in either direction. Second, rancidity: oxidised oil smells stale, feels different, and is more likely to irritate; carriers keep best sealed, cool, dark and dated, and an unlabelled bottle of unknown age is not a saving. Third, a point that matters in a house like this one: oil of any kind, vegetable or mineral, weakens latex. Public-health guidance on condom use is explicit that oil-based products, massage oils included, should not be used with latex, and that water-based or silicone-based lubricants are the compatible ones. That is general safety information worth knowing independently of any setting.

The word "oil" in "essential oil" is a historical accident, and almost every safety mistake people make with these materials follows from taking it literally. An essential oil is not a fat. It contains no triglycerides and no glycerol backbone. It is a concentrated mixture of small, volatile, aromatic molecules — terpenes and terpenoids, aldehydes, esters, ketones, phenols — which is precisely why you can smell it across a room and why a drop left on a saucer will be gone by morning. Fat does not do that.

The international vocabulary standard for these materials, ISO 9235, defines an essential oil by how it is obtained rather than by what it does: a product obtained from a natural raw material of plant origin by steam distillation, by mechanical processes from the epicarp of citrus fruits, or by dry distillation, with the aqueous phase separated by physical means. Those three routes are worth keeping distinct. Steam distillation carries volatile compounds over with steam and condenses them — most floral, herb and needle oils arrive this way. Expression is purely mechanical: the outer peel of a citrus fruit is abraded or pressed at ambient temperature and the contents of the ruptured oil cavities are recovered. Dry distillation, applied to woods, barks and roots, uses no added water or steam at all. That distinction between distilled and expressed is not trivia; it reappears with force in the section on phototoxicity, because the compounds responsible for phototoxic burns are heavy and largely do not survive the journey through a still.

The other consequence of the chemistry is concentration. A small bottle represents the volatile fraction of a large mass of plant material, and the molecules inside behave on skin much more like solvents than like fat: they penetrate, they evaporate, and applied undiluted they are drying. This is the entire reason dilution exists as a discipline. A carrier oil is not there to make an essential oil go further or to make it cheaper. It is there to hold a very concentrated, mobile material at a concentration a human being’s skin and immune system can tolerate, and to slow its delivery. Everything in the next section follows from that.

The Tisserand Institute’s published safety guidelines put the central instruction about as plainly as it can be put: "Do not apply undiluted essential oils to your skin. It’s that simple." Its dilution guidance for adults places body oils and massage blends in the region of 1–3 per cent, facial preparations lower at roughly 0.5–1.2 per cent, and preparations for sensitive or impaired skin lower again at around 0.2–1 per cent. The National Association for Holistic Aromatherapy’s published safety position is consistent with that: avoid undiluted application, avoid application to damaged or inflamed skin, and treat roughly 2 per cent for the body and 1 per cent for the face as the working figures for a healthy adult. NAHA states explicitly that it does not support the use of "drop therapies" that apply undiluted dermally sensitising oils.

The reasoning behind the numbers is worth stating because it cuts against an intuition many people hold. Higher is not stronger in any useful sense. As the Tisserand Institute puts it, increasing concentration always increases risk, but may not increase benefit. Undiluted application is discouraged because it is the single most common route to the adverse reactions that actually send people to a dermatologist: irritation, chemical burns in some cases, and — the one that does not go away — sensitisation. There is no aromatic effect available at 50 per cent that is not available at 2 per cent, because the nose is not the limiting factor. The skin is.

Two practical notes attach to this. Drops are a poor unit: no two drops of essential oil are the same size, viscosity varies between oils, and dropper inserts vary between bottles, which is why percentages by volume or weight are the professional convention and why a recipe written in drops should be read as an approximation. And essential oils should not be dropped neat into a bath. They do not dissolve in water; they float as undiluted droplets and attach to skin at full strength, which is the opposite of dilution. Separately, the same guidelines advise against direct, intensive inhalation — steam inhalation, for example — for longer than about fifteen to twenty minutes.

To say it once more in the plainest terms, because this is the section people skim: this page gives no dilution instruction for you to follow at home and recommends no oil for any purpose. The figures above are reported so that you can recognise whether someone who is working on you is inside or outside professional practice. If you intend to use these materials yourself, the person to ask is a qualified professional.

This is the safety issue that most deserves its reputation, because the mechanism is specific, the consequences are visible for weeks, and the people it catches are usually doing something they were told was harmless. Expressed citrus peel oils contain furanocoumarins, a class of compounds also called psoralens. The most significant of them in this context is bergapten, otherwise known as 5-methoxypsoralen or 5-MOP, a linear furanocoumarin and the most potent of the group. Furanocoumarins on skin absorb ultraviolet light and, in doing so, produce a severe delayed burn in the exposed area. A documented case in the dermatological literature — Clark and Wilkinson, Contact Dermatitis, 1998 — records phototoxic contact dermatitis traced specifically to 5-methoxypsoralen in an aromatherapy oil.

Which oils. The Tisserand Institute lists expressed bergamot, lime, lemon, grapefruit and bitter orange as the phototoxic ones. It lists as non-phototoxic the distilled versions of citrus oils, which contain very much less furanocoumarin content, the heavy furanocoumarin molecules largely not surviving distillation, along with mandarin, tangerine, yuzu, caraway, ginger, parsley herb and patchouli. This is why "citrus" is not a usable category for safety purposes. Expressed bergamot and steam-distilled bergamot are chemically different products that share a plant name, and expressed sweet orange behaves differently again from expressed bergamot. Anyone handling these materials professionally needs to know which bottle they have.

The numbers that regulate this are strict and small. The IFRA limit for bergamot oil in leave-on products applied to skin exposed to sunlight is 0.4 per cent. Separately, the IFRA and EU limit on bergapten itself in leave-on finished products is 15 parts per million — 0.0015 per cent. Read those two figures next to the general massage dilution of 1–3 per cent and the point lands: a phototoxic citrus oil cannot simply be used at an ordinary massage percentage. It is capped an order of magnitude below.

Timing and format matter too. Guidance is to keep treated skin away from ultraviolet exposure — sunlight and tanning beds alike — for at least twelve hours and possibly longer, and to bear in mind that a phototoxic burn continues to worsen for one to three days after the exposure, so the absence of a reaction that evening means nothing. Wash-off products present negligible risk, because the material does not remain on the skin. Practically, for a reader: if you have had an oil blend left on your skin and you do not know what was in it, ask, and ask before going out into the sun rather than afterwards.

Irritation and sensitisation are commonly confused and are not the same event. Irritation is a direct, dose-related response: too much material, too concentrated, and the skin objects immediately. Sensitisation is immunological. It can develop after a series of exposures that each passed without incident, it can appear the first time at a concentration that was previously fine, and once the immune system has learned a molecule, that learning is generally for life. This is why the concentration limits in the previous section are framed as risk management rather than as comfort thresholds: the goal is not to avoid stinging today but to avoid acquiring a permanent allergy over months.

The mechanism that drives most of it is oxidation, and it is the least intuitive part of this subject. Several of the commonest constituents in aromatic materials — limonene, linalool, linalyl acetate, alpha-terpinene, geraniol — are what the dermatological literature calls prehaptens: they are weak sensitisers as they come out of the plant, but they autoxidise on contact with air, and the hydroperoxides formed by that autoxidation are the actual potent allergens. In consecutive series of dermatitis patients, contact allergy to oxidised R-limonene has been reported at around 5.2 per cent and to oxidised linalool at around 6.9 per cent, placing them among the more frequently identified contact allergens. Tea tree oil is the textbook case: research in Contact Dermatitis has established that the sensitising agents are degradation products — ascaridole prominent among them, alongside terpinolene, alpha-terpinene and alpha-phellandrene — rather than the fresh oil, and that an opened bottle exposed to air, light, warmth and humidity can develop them within days to months.

The regulatory response reflects how seriously this is taken. Under the EU Cosmetics Regulation as amended by Commission Regulation (EU) 2023/1545, the list of fragrance allergens that must be individually declared on a label was expanded from 26 to more than eighty individual substances and groups, with compliance required for products placed on the market from 31 July 2026 and for existing stock by 31 July 2028. Limonene and linalool are among the substances on that list. Whatever else one thinks about fragrance regulation, a labelling regime of that size is not built around a theoretical hazard.

What follows practically is storage and honesty about age. Aromatic materials keep best in small, full, tightly sealed, dark bottles, cool and out of the light, with the date of opening written on them; a half-empty bottle has a headspace full of oxygen and is ageing faster than a full one. Citrus oils in particular are worth retiring early. And a bottle whose opening date nobody knows should be treated as an unknown substance, because chemically it is one.

Patch testing is the precaution most often advised in professional aromatherapy safety practice: a small quantity of the blend, at the dilution it will actually be used at, placed on the inner forearm and left undisturbed, with the site checked at 24 and again at 48 hours, since allergic responses can take anywhere from about 12 to 72 hours to declare themselves. Two honest caveats belong with it. A negative result does not guarantee that sensitisation will not develop later with repeated exposure — that is exactly how sensitisation works. And this home precaution is not the same thing as diagnostic patch testing, which is a clinical procedure performed and interpreted by a dermatologist. If you have reacted to a fragranced product before, that is a conversation for a doctor, not for a bottle.

The Tisserand Institute states the general rule in a single sentence, and it is a good one to carry: if you have a skin condition, are pregnant, have epilepsy or asthma, are on a course of treatment with prescribed medication, or are in any doubt about any condition you may have, you are advised to seek the advice of a doctor or suitable practitioner before using pure essential oils. Everything below expands on parts of that sentence. None of it is a diagnosis, and none of it assumes anything about the reader.

Pregnancy. The honest summary is that human safety data are thin, and that most of what is known comes from animal reproductive-toxicity studies whose extrapolation to humans is imperfect and acknowledged to be so. A 2021 peer-reviewed review of maternal reproductive toxicity of essential oils and their constituents concluded that oils or components showing animal reproductive toxicity should either be prohibited or restricted during pregnancy and lactation, and that in the absence of clinical evidence in humans it is best to avoid or restrict potentially dangerous constituents. Constituents it identifies as of concern include sabinyl acetate, pulegone, thujone, anethole, citral and methyl salicylate. This page will not tell you what is fine and what is not, because that is a decision for you and your maternity care provider, made with knowledge of your pregnancy and not of a general readership. What this page will say is: raise it before a session, not during one.

Seizure disorders. This caution is not folklore. Burkhard and colleagues, writing in the Journal of Neurology in 1999, described the essential oils of eleven plants — eucalyptus, fennel, hyssop, pennyroyal, rosemary, sage, savin, tansy, thuja, turpentine and wormwood — as powerful convulsants on account of their content of reactive monoterpene ketones, among them camphor, pinocamphone, thujone, cineole, pulegone, sabinyl acetate and fenchone, and reported three previously healthy patients who had seizures in connection with the therapeutic use of such oils. Later case series and prospective work have continued to report essential-oil-related seizures in adults and children. Anyone with epilepsy, a seizure disorder, or any history of seizures should take the question of aromatic exposure to their own physician before it arises in a treatment room.

Respiratory sensitivity, skin conditions, medication and children. Strong aromatics in an enclosed room can provoke symptoms in people with asthma or other respiratory sensitivity, and a diffused room is not a neutral environment for someone who reacts to it — which is a reason to ask rather than to assume. Application to broken, inflamed or already irritated skin is advised against across professional guidance. Anyone on prescribed medication falls inside the Tisserand Institute sentence above and should ask. And children and infants are outside the scope of this page entirely; the dilutions are much lower and the considerations are different.

One line to close this section, stated as flatly as possible: this page recommends no essential oil for any condition, symptom, mood or outcome, and nothing in it should be read as suggesting that a reader has a condition or needs one addressed. If a caution above applies to you, the right next step is a conversation with a qualified professional.

Two things are true at the same time, and most writing on this subject picks one and suppresses the other. The first is that across a good many small trials in a good many settings, people report modest improvements in subjective relaxation, anxiety and sleep quality when aromatic materials are part of the setting. The second is that the field is built on a mountain of claims — antimicrobial, hormonal, immune, curative, detoxifying — that the research does not support, and that the evidence for even the modest findings is rated, by the people best placed to rate it, as low or very low certainty. Both halves are reported here.

The Cochrane reviews are the least flattering and the most useful. "Aromatherapy for dementia" (Ball and colleagues, 2020) included thirteen studies and found no convincing evidence that aromatherapy is beneficial for people with dementia; conduct or reporting problems in half the included studies meant they could not contribute to the conclusions at all, the results of the rest were inconsistent, and harms were very poorly reported. "Aromatherapy and massage for symptom relief in people with cancer" downgraded the GRADE certainty of evidence to very low for every outcome it examined — pain, anxiety, depression, mood, nausea, fatigue, quality of life — citing imprecision, indirectness, baseline imbalance and study design limitations, noting that most studies were small and at unclear or high risk of bias, and recording that only two of nineteen studies reported adverse events at all. "Aromatherapy for pain management in labour" (Smith and colleagues, 2011) found two randomised trials covering 535 women and concluded that the efficacy and effectiveness of aromatherapy has not been established, and that implications for clinical practice cannot be drawn.

Where the literature is friendlier — the meta-analyses of aromatherapy for sleep quality and for anxiety that report favourable pooled effects — the reviews themselves almost invariably attach a certainty rating of low, and attribute it to high risk of bias and poor quality among the included studies. That pattern deserves to be read properly rather than quoted selectively. A favourable pooled effect estimate and a low certainty rating are not contradictory; they say that a positive result was observed and that the design of the studies producing it does not let anyone be confident it reflects the intervention. Citing the first half without the second is the single most common move in aromatherapy marketing.

The reason the certainty ratings keep coming out low is worth understanding, because it is structural rather than accidental. You cannot blind a smell. A participant knows whether the room smells of lavender. An unscented control does not mimic the sensory experience of the intervention, and a scented control cannot be assumed to be inert, so neither option gives a clean comparison; reviews of this literature repeatedly name the near-impossibility of blinding as a core limitation. What that opens the door to was demonstrated directly by Howard and Hughes in the British Journal of Health Psychology in 2008: ninety-six healthy women were exposed to lavender, a placebo aroma, or no aroma during physiologically measured relaxation, with their expectations about the aroma primed by instruction. There was no effect of aroma on galvanic skin response. What moved the outcome was what participants had been told to expect — those primed to expect inhibition relaxed more, those primed to expect facilitation relaxed less. The aroma did not do the work; the expectation did.

This does not mean nothing happens in a room with a smell in it. Expectancy effects are real effects experienced by real people, and a person who finds a session more restful because she likes how it smells has genuinely had a more restful session. What the finding removes is a specific causal claim — that a particular molecule acted on her physiology to produce the state — and that claim is precisely the one used to sell things. The distinction is not pedantry. It is the difference between "you may well enjoy this" and "this will do something to you."

On the larger claims, briefly and without making any of them. There is a very large in vitro literature reporting antimicrobial activity for essential oils against various organisms in laboratory conditions; reviews of that literature identify inconsistent composition between samples, the absence of standardised assays, and limited in vivo evidence as the barriers to translating any of it into clinical use. A result in a dish is not a result in a person, and this page makes no antimicrobial claim of any kind. The same discipline applies to hormonal, immune, curative and detoxifying claims: they are not made here, and where they circulate they run far ahead of what has been shown.

One contrast is worth drawing because it is so often blurred. The lavender preparation with the strongest clinical trial record is Silexan, an 80 mg oral soft-gelatine capsule of steam-distilled lavender flower oil, licensed as a medicine in Germany since 2009 and studied in randomised trials against placebo and against comparator drugs. Swallowing a standardised pharmaceutical dose under a marketing authorisation is a categorically different intervention from smelling a diffuser or having a diluted blend stroked into a shoulder. Trials of the former say nothing whatever about the latter, and nothing on this page concerns that product or suggests anyone use it. It is mentioned only because its results are routinely borrowed to dignify claims about things that are not it.

And to repeat the disclosure from the top of this page, in the place where it costs something: this house sells bodywork with an aromatic oil option. It benefits if you believe aroma is effective. The paragraphs above are what the research says anyway.

The anatomy is genuinely unusual, and it is worth stating accurately because the accurate version is more interesting than the slogan. Olfactory receptor neurons in the nasal epithelium project to the olfactory bulb, where the glomeruli are the sole relay for olfactory input. The axons of the bulb’s mitral and tufted cells form the lateral olfactory tract and project to the piriform cortex, the olfactory tubercle, parts of the amygdala and the entorhinal cortex. That last destination matters, because the entorhinal cortex is the principal gateway to the hippocampus. And unlike vision, hearing and touch, this output reaches cortex without an obligatory synapse in the thalamus first.

That is where the popular version usually stops, and it is where it goes slightly wrong. Olfactory information does reach the thalamus by indirect routes, by way of the mediodorsal nucleus, so "the only sense that bypasses the thalamus entirely and goes straight to emotion" is a simplification that has hardened into a fact through repetition. What the anatomy establishes is proximity: olfactory input arrives early in structures heavily involved in emotion and in memory formation. Proximity is not a mechanism, and it is certainly not a lever that a practitioner can pull.

The psychological finding underneath the folklore is real and has held up. Willander and Larsson, in Psychonomic Bulletin & Review in 2006, compared autobiographical memories cued by odours with memories cued by words and by pictures. Odour-cued memories were older, clustering in the first decade of life rather than in the adolescent and early-adult years where verbally cued memories concentrate, and were accompanied by a stronger sense of being brought back in time to the original event. That is a genuine and replicated asymmetry between the senses, and it is a fair description of why a particular smell can ambush a person.

What it is not is evidence that a scent can be selected in advance to produce a chosen emotion in a particular person. The associations are personal and largely unpredictable from the outside. A note that reads as comforting to one person is a hospital corridor to another, a funeral, a former partner, a bathroom cleaner, or a summer she would rather not revisit. This is the practical reason a competent practitioner asks which of a small set you like rather than announcing which one is calming — and it is also a reason a person may prefer no aroma at all on a given day, which is a preference and not a problem.

A Japanese reader does not arrive at the subject of aroma through aromatherapy. She arrives through 香り, and specifically through a tradition that is counted among the classical arts of refinement alongside 茶道 and 華道. 香道 took its organised form in the Muromachi period, around the circle of Ashikaga Yoshimasa, with the codification of its procedures associated with figures including Sanjōnishi Sanetaka and Shino Sōshin. Its material is aromatic wood — 沈香 and sandalwood among others — warmed rather than burned, and its characteristic verb is not smelling but 聞く: 聞香, listening to incense. The register is attention and discrimination, an exercise in noticing. It is worth naming here because it is a long-established tradition of taking scent extremely seriously that never once claimed to cure anything.

The regulatory position is a separate question, and it should be stated plainly because it is frequently obscured. There is no national qualification for aromatherapy in Japan. The 公益社団法人日本アロマ環境協会 (AEAJ) says so on its own published FAQ: 現在、日本にはアロマテラピーに関する国家資格はありません, and its own certifications — アロマテラピー検定, アロマテラピーアドバイザー, アロマセラピスト and the rest — are 民間資格, association qualifications, with AEAJ noting that it is the only public interest incorporated association certifying in this field. This is not a criticism of those qualifications, which involve real training. It is a statement of what they legally are.

The contrast that makes this concrete is close at hand. あん摩・マッサージ・指圧 is a licensed occupation in Japan under 昭和22年法律第217号, which is why this chamber keeps Japanese regulation as a separate lens at all: in this country some of the words used for bodywork are legally defined and some are not, and the difference is invisible from a website. "Aromatherapist" and "licensed あん摩マッサージ指圧師" are not the same kind of word.

Product law matters here too. Most essential oils sold in Japan are not approved as 医薬品 or 医薬部外品 and are handled as 雑貨 or, where they are intended for application to skin, as 化粧品. Under Article 68 of the 医薬品医療機器等法 — the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices — no person may advertise the name, manufacturing method, efficacy, effect or performance of an unapproved drug, medical device or regenerative medicine product. In practice that means a Japanese seller who tells you a bottle treats a condition is not merely overreaching editorially; they are in regulated territory. The useful inference for a reader runs the other way, though, and is worth holding onto: the absence of efficacy language on a Japanese aroma product is a legal fact about advertising law. It is not evidence that the product works, and it is not evidence that it does not.

Concretely, the option is this: a carrier oil, warmed in the hands, with or without a diluted aromatic blend chosen from a small set according to what you like. It is offered because oil makes a particular kind of long, continuous, non-dragging contact possible, and because some people find that a smell they like makes a room easier to be in. That is the whole of the claim.

What you might reasonably expect: better glide and less drag, so that pressure arrives as pressure rather than as pulling; warmth; a smell you like, or one you are indifferent to; possibly a pleasant and restful state; possibly nothing in particular beyond a comfortable ninety minutes. Every item on that list is an acceptable outcome, including the last one. A session that was simply comfortable has not failed.

What it is not, stated once and without hedging: it is not treatment, rehabilitation, correction or diagnosis. Nothing is cured, nothing is detoxified, nothing is claimed about immunity, hormones, infection or any disease process. If you want a clinical intervention, the people who provide those are licensed to do so and this is not that.

What is useful to say beforehand: any allergy, and specifically any nut allergy, since nut-derived carrier oils exist and can be swapped out; any skin condition or broken skin; pregnancy; any history of seizures; asthma or respiratory sensitivity; prescribed medication; whether you have ever reacted to a fragranced product; and whether you are going out into strong sunlight afterwards, which bears directly on the citrus question above. None of that is interrogation. It is the information required to make a sensible choice of bottle.

And the parts that are simply yours to decide: you may have unscented carrier oil and no aroma at all, and that is an ordinary choice rather than a reduced version of anything. You may change your mind partway through, including about the smell. You may ask what is in the bottle and expect a specific answer rather than a poetic one. If the honest answer to a question is that the evidence does not support what you were hoping to hear, you will be told that instead.